Jane Street Group, LLC Seres Therapeutics, Inc. Put Options Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 15, 2022
BUY
$6.02 - $11.43 $79,464 - $150,876
13,200 Added 16.06%
95,400 $795,000
Q3 2021

Nov 16, 2021
BUY
$5.46 - $22.6 $252,798 - $1.05 Million
46,300 Added 128.97%
82,200 $572,000
Q2 2021

Aug 16, 2021
BUY
$18.46 - $24.36 $341,510 - $450,660
18,500 Added 106.32%
35,900 $856,000
Q1 2021

May 18, 2021
SELL
$17.66 - $28.92 $490,948 - $803,976
-27,800 Reduced 61.5%
17,400 $358,000
Q3 2020

Nov 17, 2020
BUY
$3.74 - $28.74 $169,048 - $1.3 Million
45,200 New
45,200 $1.28 Million

Others Institutions Holding MCRB

# of Institutions
82
Shares Held
40.5M
Call Options Held
304K
Put Options Held
471K
View Full List

About Seres Therapeutics, Inc.

MCRB Quotes by TradingView
  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $110M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email